NIH-funded research R01 grant

Editing a gene to reduce heart disease risk

Official title: Targeted editing of ASGR1 for cardiovascular diseases

Funded at Indiana University Indianapolis · NIH-11056893 · Data updated 2026-11-12

This study is looking at a new way to help lower cholesterol and improve heart health by targeting a specific gene, and it could be especially helpful for people with high cholesterol or triglyceride levels.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis
NIH-funded
Lab location1 site (Indianapolis, United States)
Project startMarch 15, 2024
Project endFebruary 28, 2028
Funding year2025
Award (this year)$636,773
NIH project number5R01HL169976-02
Project IDNIH-11056893 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with high cholesterol or triglyceride levels who are at risk for cardiovascular diseases.

Less likely to help

Patients who have normal cholesterol levels and are not at risk for cardiovascular diseases may not benefit from this research.

What this research studies

This research focuses on developing a new therapy to lower cholesterol levels and reduce the risk of cardiovascular diseases by targeting a specific gene called ASGR1. The approach involves using engineered viral-like particles to deliver a base editing technique that can modify this gene. By studying this method in preclinical models, the researchers aim to create a one-time treatment that could significantly improve lipid metabolism and cardiovascular health. Patients with high cholesterol or triglyceride levels may find this research particularly relevant.

Why it matters

Potential benefit: If successful, this research could lead to a groundbreaking treatment that significantly lowers cholesterol levels and reduces cardiovascular disease risk for patients.

How similar studies have gone: Previous research has shown promising results in targeting similar pathways for cholesterol management, indicating potential success for this novel approach.

Where this research is happening

  • Indiana University Indianapolis
    Indianapolis, United States
    Active

Researchers

  • Principal investigator: Han, Renzhi — Indiana University Indianapolis
  • Study coordinator: Han, Renzhi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.